Finished
Clinical Investigation to Validate the Safety and Performance of Integrating Functional Electrical Stimulation Into the ABLE Exoskeleton
NCT07550699 · ABLE Human Motion S.L. · Updated 8 Sept 2026
- What is being tested
- ABLE Exoskeleton with Functional Electrical Stimulation (ABLE FES)
- For
- Acquired Brain Injury (Including Stroke); Spinal Cord Injury; Multiple Sclerosis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 14 people. The full rules are on the registry page.
- Where
- Austria
- When
- Starts or started 20 April 2026, ends 3 Sept 2026. Registered 24 April 2026.
- Results
- None posted yet.
In the researchers' words
The primary objective of this study is to validate the safety and clinical performance of the ABLE Exoskeleton with integrated Functional Electrical Stimulation (ABLE FES) in individuals with neurological conditions that impair gait, including spinal cord injury, acquired brain injury, and multiple sclerosis. The secondary objective is to collect preliminary data on the potential clinical and psychosocial benefits of combining robotic gait assistance with electrical stimulation.
Sites
- therapy2people GmbHVienna, State of Vienna, Austria